Published in AIDS Weekly, May 12th, 1997
The assay may even lead to a way to test patients' infectious viral burden, perhaps yielding previously unavailable prognostic data.
Currently, HIV infectivity is monitored by assessing viral p24 antigen production or by HeLa-CD4 plaque assays. Both tests are time consuming and yield limited data.
Now University of California, San Diego researchers Alain Gervaix and colleagues report the development of a new assay: a CEM cell line containing a plasmid encoding the green fluorescent protein (humanized S65T GFP) driven by the HIV-1 long terminal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-05-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.